10th Annual HSCI Malkin Retreat
"Nobody was ever cured by injecting themselves with a paper in Nature," Harvard Stem Cell Institute co-director Doug Melton said, kicking off HSCI's 10th Annual Malkin Retreat.
Melton reminded the more than 300 assembled scientists from all across the Harvard Stem Cell world that while HSCI's first decade of establishing a collaborative environment, focusing on new ideas and on young scientists - and supporting exciting new research with the Seed Grant program, has been enormously successful, the aim in the coming decade has to be on treating and curing disease.
HSCI scientists, Melton said, need to be working more and more in partnerships - with each other, with foundations, and with industry - to lift their science out of journals and into the clinic as quickly and successfully as possible.
One of HSCI's greatest "strengths is bringing together people who think in different ways but are interested in the same type of questions," said Paola Arlotta, co-program leader of HSCI's Nervous System Diseases Program and a faculty co-chairs for this year's retreat.
Each featured speaker discussed a different approach to solving common biological challenges, from drug delivery, to stem cell transplants as treatments, to developing therapies for diseases, to the very basic question of how to classify a cell.
Read more about the speakers and events at the 10th Annual HSCI Malkin Retreat here.
|